Biggest News Aggregation in the World
📰 Action Indicated News

Page 5 - Action Indicated News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Action Indicated. Real-time updates on events, politics, business and more.

RPT-EXCLUSIVE-Lilly hit by staff accusations, FDA scrutiny at COVID drug factories

RPT-EXCLUSIVE-Lilly hit by staff accusations, FDA scrutiny at COVID drug factories Reuters 3 hrs ago (Repeats to additional subscribers with no changes to the text) By Dan Levine and Marisa Taylor May 5 (Reuters) - Eli Lilly & Co employees have accused a factory executive of altering documents required by government regulators in an effort to downplay serious quality control problems at the U.S. plant producing the drugmaker’s COVID-19 treatment, according to an internal Lilly complaint and...
United States New Jersey Southern Methodist University San Francisco Lydia Wible Michele Gershberg
Source: msn.com

Lilly hit by staff accusations, FDA scrutiny at Covid-19 drug factories

Read more about Lilly hit by staff accusations, FDA scrutiny at Covid-19 drug factories on Business Standard. (Reuters) - Eli Lilly & Co employees have accused a factory executive of altering documents required by government regulators in an effort to downplay serious quality control problems at the U.S. plant producing the drugmakers COVID-19
South Korea United States New Jersey Southern Methodist University San Francisco Lydia Wible

Lilly hit by staff accusations, FDA scrutiny at COVID drug factories

Message : Required fields (Reuters) - Eli Lilly & Co employees have accused a factory executive of altering documents required by government regulators in an effort to downplay serious quality control problems at the U.S. plant producing the drugmakers COVID-19 treatment, according to an internal Lilly complaint and a source familiar with the matter. The unsigned report, filed April 8 in Lillys confidential employee complaint system and reviewed by Reuters, is the latest sign of manufacturi...
United States New Jersey Southern Methodist University San Francisco Lydia Wible Michele Gershberg

Whistleblower raises hygiene concerns from 2018 FDA inspection of Merck's Durham plant

Whistleblower raises hygiene concerns from 2018 FDA inspection of Mercks Durham plant Zachery Eanes, The News & Observer (Raleigh, N.C.) Apr. 2—DURHAM — Inspection officials from the U.S. Food and Drug Administration improperly downgraded hygiene concerns in 2018 at Mercks Durham facility — a vaccine manufacturing plant that stands to play a key role in producing Johnson & Johnsons one-shot COVID-19 vaccines, according to a complaint filed by an FDA whistleblower. The whis...
United States New York University Of Pennsylvania White House District Of Columbia West Point
Source: msn.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science